Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifidice in Irritable Bowel Syndrome
NCT05663060Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Open-label trial in irritable bowel syndrome (IBS), sponsored by Humanitas Research Hospital. Primary endpoint: Modification of the intestinal microbiota at 12 months. Started Dec 2022; status: completed.
02
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT05663060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05663060.